Profound Medical (PROF)
NASDAQ:PROF
Holding PROF?
Track your performance easily

Profound Medical (PROF) Ownership - Who Owns Profound Medical?

59 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value
Aug 17, 2024
Rashed Osman Dewan
Chief Financial Officer
xxxxxxxxxxxxx
C$125480
Mar 28, 2024
Abbey Klair Goodman
Regional Head
xxxxxxxxxxxxx
$70099
Dec 23, 2023
Mathieu Burtnyk
Senior Officer
xxxxxxxxxxxxx
C$40988
Dec 23, 2023
Mathieu Burtnyk
Senior Officer
xxxxxxxxxxxxx
C$77090

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
13,441,792Insider54.91%103,300,172
11,828,144Insider48.31%90,899,287
11,828,144Insider48.31%90,899,287
7,400,000Insider30.23%56,869,000
565,798Institution2.31%4,348,158
543,448Insider2.22%4,176,398
332,133Institution1.36%2,552,442
215,000Institution0.88%1,652,275
96,663Institution0.39%742,855
68,000Insider0.28%522,580

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
332,133Institution1.36%2,552,442
96,663Institution0.39%742,855
14,049Institution0.06%107,967

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value

FAQ

Who Owns Profound Medical (PROF)?
Currently, no data Available
What percentage of Profound Medical (PROF) stock is held by institutional investors?
Currently, no data Available
What percentage of Profound Medical (PROF) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Profound Medical (PROF)?
Bdc owns the most shares of Profound Medical (PROF).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
      What am I Missing?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis